Trial intelligence / Profile preview

INC280 ± erlotinib vs platinum + pemetrexed in MET-amplified EGFR-mutant NSCLC after EGFR TKI

CTR20160944Phase 2Suspended

Sponsor

Novartis

Start

Feb 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1